[HTML][HTML] Effectiveness of Amlodipine in the Control of 24-Hour Blood Pressure in Mild-to-Moderate Essential Hypertension: A Prospective, Multicenter, Observational …
D Prabhakar, S Guha, R Rathod, K Gaurav - Cureus, 2023 - ncbi.nlm.nih.gov
D Prabhakar, S Guha, R Rathod, K Gaurav
Cureus, 2023•ncbi.nlm.nih.gov… This practice-based, observational, real-world evidence study assessed the 24-hour
ambulatory blood pressure (ABP) control in mild-to-moderate essential hypertensive
patients (treatment naïve receiving amlodipine monotherapy, or as add-on therapy) in
inadequately controlled blood pressure (BP goal not met after one month of existing therapy).
One hundred four (62M/42F) patients between 18 and 65 years of age who received …
Although amlodipine is one of the preferred first-line anti-hypertensive, data on 24-hour BP …
ambulatory blood pressure (ABP) control in mild-to-moderate essential hypertensive
patients (treatment naïve receiving amlodipine monotherapy, or as add-on therapy) in
inadequately controlled blood pressure (BP goal not met after one month of existing therapy).
One hundred four (62M/42F) patients between 18 and 65 years of age who received …
Although amlodipine is one of the preferred first-line anti-hypertensive, data on 24-hour BP …
Abstract
Background
Calcium-channel blockers (CCB) are a mainstay in the management of hypertension (HTN), and amlodipine is the preferred CCB due to its longer half-life and better safety.
ncbi.nlm.nih.gov
以上显示的是最相近的搜索结果。 查看全部搜索结果